Home » Zofran » Zofran Heart Defects

Zofran Heart Defects

• More on Zofran
  • Zofran Side Effects
  • Zofran Hypospadias
  • Zofran Hydronephrosis
  • Zofran Kidney Defect
  • Zofran Fetal Growth Restriction
  • Zofran Musculoskeletal Defects
  • Zofran Cleft Palate
  • Zofran Cleft Lip
  • Zofran Hole in the Heart
  • Zofran Ventricular Septal Defect
  • Zofran Atrial Septal Defect
  • Zofran Heart Murmur
  • Zofran Heart Defects
  • Zofran Birth Defects
  • Zofran Lawsuit

Zofran, an anti-nausea medication that is widely prescribed to treat morning sickness, may increase the likelihood that a baby will be born with serious heart birth defects and other major congenital abnormalities. Plaintiffs who have filed lawsuits over alleged Zofran heart defects claim that GlaxoSmithKline aggressively marketed the medication as an appropriate treatment for pregnancy-related nausea and vomiting, even though it has never been approved for this indication. They also accuse the company of failing to warn patients and doctors about the risks potentially associated with Zofran.

Zofran Heart Defects Investigation

The Zofran legal team at Bernstein Liebhard LLP is investigating potential product liability claims on behalf of children who allegedly developed the following heart defects due to pre-natal Zofran exposure:

• Heart Murmur
• Atrial Septal Defect
• Ventricular Septal Defect
• Hole In The Heart

If you think Zofran harmed your child, please call (888) 994-5118 to arrange for a free legal consultation.

Zofran Litigation

Since February 2015, a growing number of Zofran heart defect lawsuits have been filed in U.S. Courts.

• October 2015: The U.S. Judicial Panel on Multidistrict Litigation (JPML) has established a centralized proceeding for all federally-filed Zofran birth defects cases in the U.S. District Court, District of Massachusetts. Read More
• September 2015: The JPML indicates that it will hear Oral Arguments regarding the creation of a new multidistrict litigation for all federally-filed Zofran lawsuits at its October 1^st Hearing Session. Read More
• April 2015: New Zofran lawsuits have been filed in Texas and Massachusetts. The Texas plaintiffs allege that Zofran was responsible for numerous congenital defects, including a heart murmur, sustained by a baby who was born in 2014. Read More
• March 2015: A lawsuit was filed in California’s Alameda Superior Court on behalf of a baby who was diagnosed with supraventricular tachycardia, a type of cardiac arrhythmia, following pre-natal Zofran exposure. Read More
• February 2015: A Zofran lawsuit filed on February 12th in the U.S. District Court, Eastern District of Pennsylvania, blames the drug for heart birth defects suffered by two children. Just four days later, a case was filed in the U.S. District Court, District of Massachusetts, alleging that pre-natal Zofran exposure caused another little girl to develop congenital heart problems and other abnormalities. Read More

Zofran and Heart Birth Defects

Zofran has been on the market since 1991. It is currently approved to treat nausea and vomiting experienced by post-op surgery patients or those undergoing certain cancer treatment. It has never been approved to treat pregnancy-related nausea and vomiting, and is classified in the U.S. Food & Drug Administration’s Pregnancy Category B. This designation indicates that the drug hasn’t been well-studied in pregnant woman.

In recent years, a number of studies have linked the use of Zofran in early pregnancy to the development of major heart defects and other congenital abnormalities.

• 2013: Researchers looking at 900,000 pregnancies included in a Danish health registry concluded that children born women who took Zofran during the first trimester were 30% more likely to develop a major birth defect, and 2 times more likely to suffer serious cardiac malformations. Among other things, the study team found that children exposed to Zofran in-utero were 2.1 times more likely to be born with an atrial septal defect; 2.3 times more likely to suffer a ventricular septal defect, and 4.8 times more likely to have atrioventricular septal defects.
• December 2014: Research appearing in Reproductive Toxicology linked pre-natal exposure to Zofran with double the risk of septal heart defects, including atrial septal defects and ventricular septal defects.

Legal Help for Zofran Heart Birth Defects

Bernstein Liebhard LLP is now offering free, no-obligation legal reviews to alleged victims of Zofran heart defects. If your baby was born with a serous heart issue following fist trimester exposure to Zofran, please call (888) 994-5118 to talk with one of our attorneys today.